| Date Filed | Type | Description |
| 06/16/2023 |
4
| Lacey David L. (Director) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Granted 6,800 shares
@ $0
Granted 19,500 options to buy
@ $19.6, valued at
$382.2k
|
|
| 06/15/2023 |
4
| Lacey David L. (Director) has filed a Form 4 on Atreca, Inc.|
Txns:
| Granted 12,000 options to buy
@ $1.18, valued at
$14.2k
|
|
| 05/04/2023 |
4
| Lacey David L. (Director) has filed a Form 4 on Nurix Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $9.44, valued at
$236k
|
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/23/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/22/2020 |
4
| Lacey David L. (Director) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Granted 25,000 options to buy
@ $9.14, valued at
$228.5k
|
|
| 06/15/2020 |
4
| Lacey David L. (Director) has filed a Form 4 on Atreca, Inc.|
Txns:
| Granted 12,000 options to buy
@ $17.87, valued at
$214.4k
|
|
| 05/26/2020 |
4
| Lacey David L. (Director) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Granted 50,000 options to buy
@ $36.34, valued at
$1.8M
|
|
| 05/26/2020 |
3
| Lacey David L. (Director) has filed a Form 3 on Arcus Biosciences, Inc. |
| 06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2019 |
3
| Lacey David L. (Director) has filed a Form 3 on Atreca, Inc. |
| 05/02/2018 |
3
| Lacey David L. (Director) has filed a Form 3 on Unity Biotechnology, Inc. |